David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Virtu Financial
VIRT
$5.85B
| $21M | 0.02% |
549,676
-427,277
| -44% | -$15.9M |
|
852
Novavax
NVAX
$1.46B
| $20.9M | 0.02% |
3,260,908
-2,529,346
| -44% | -$20.9M |
|
853
Euronet Worldwide
EEFT
$2.63B
| $20.9M | 0.02% |
195,139
+81,800
| +72% | +$8.29M |
|
854
G-III Apparel Group
GIII
$1.43B
| $20.8M | 0.02% |
762,063
+448,901
| +143% | +$13M |
|
855
CALL
HCA Healthcare
HCA
$92.9B
| $20.8M | 0.02% |
60,300
+20,000
| +50% | +$6.43M |
|
856
PUT
Intuit
INTU
$101B
| $20.8M | 0.02% |
33,900
+25,600
| +308% | +$15.4M |
|
|
HUT
857
Hut 8
HUT
$9.81B
| $20.8M | 0.02% |
1,790,394
+467,080
| +35% | +$8.62M |
|
858
CALL
Ulta Beauty
ULTA
$23.2B
| $20.8M | 0.02% |
56,700
-53,700
| -49% | -$20.5M |
|
859
Leggett & Platt
LEG
$1.28B
| $20.8M | 0.02% |
2,625,701
+656,763
| +33% | +$6.23M |
|
860
Gibraltar Industries
ROCK
$1.37B
| $20.7M | 0.02% |
353,399
+161,301
| +84% | +$10M |
|
861
Core Scientific
CORZ
$5.55B
| $20.6M | 0.02% |
2,849,962
+2,154,292
| +310% | +$24.5M |
|
862
NETSCOUT
NTCT
$2.75B
| $20.6M | 0.02% |
979,121
-34,089
| -3% | -$766K |
|
863
CALL
Lowe's Companies
LOW
$122B
| $20.5M | 0.02% |
87,800
-232,100
| -73% | -$57.1M |
|
864
PUT
ServiceNow
NOW
$132B
| $20.5M | 0.02% |
128,500
-25,500
| -17% | -$4.92M |
|
865
AB InBev
BUD
$156B
| $20.5M | 0.02% |
332,335
+284,546
| +595% | +$15.6M |
|
866
Badger Meter
BMI
$3.94B
| $20.4M | 0.02% |
107,468
+21,703
| +25% | +$4.53M |
|
867
CALL
Upstart Holdings
UPST
$2.91B
| $20.4M | 0.02% |
442,700
-868,600
| -66% | -$54M |
|
868
CrowdStrike
CRWD
$194B
| $20.3M | 0.02% |
230,612
+130,772
| +131% | +$12.5M |
|
869
Teradata
TDC
$2.56B
| $20.3M | 0.02% |
904,178
+260,924
| +41% | +$7.06M |
|
870
Eldorado Gold
EGO
$12.1B
| $20.2M | 0.02% |
1,202,219
+572,453
| +91% | +$8.6M |
|
871
Freshpet
FRPT
$3.68B
| $20.2M | 0.02% |
242,355
-454,822
| -65% | -$55.7M |
|
872
Ultragenyx Pharmaceutical
RARE
$2.54B
| $20.1M | 0.02% |
556,417
+270,338
| +94% | +$11.2M |
|
873
Expedia Group
EXPE
$40.7B
| $20.1M | 0.02% |
119,803
+43,071
| +56% | +$7.85M |
|
874
Dentsply Sirona
XRAY
$2.17B
| $20.1M | 0.02% |
1,345,589
+348,174
| +35% | +$6.17M |
|
875
Fox Factory Holding Corp
FOXF
$910M
| $20.1M | 0.02% |
860,002
+38,622
| +5% | +$1.03M |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.